108937 ⎘
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes; Hydrolases (3) acting on ester bonds (3.1) Ribonucleases RNAses, DNAses
COMPOSITIONS AND METHODS FOR DETECTING NUCLEIC ACID-PROTEIN INTERACTIONS
#3002METHODS OF PERFORMING RNA TEMPLATED GENOME EDITING
#3003TRANSGENIC T CELL AND CHIMERIC ANTIGEN RECEPTOR T CELL COMPOSITIONS AND RELATED METHODS
#3004COMPOSITIONS AND METHODS OF USING ENGINEERED FUSION PROTEINS THAT BIND G4C2 HUMAN REPEATS
#3005METHOD OF TRANSACTIVATING A HOMOLOGOUS GENE OF A GENE OF INTEREST AND AN IN VITRO METHOD OF DIAGNOSING A DISEASE
#3006REPORTER CONSTRUCTS, COMPOSITIONS COMPRISING THE SAME, AND METHODS OF USE THEREOF
#3007IMPROVEMENTS IN OR RELATING TO NICKING ENZYMES
#3008PROXIMITY-DRIVEN ACTIVATION OF CRISPR-CAS SYSTEMS FOR DETECTION OF DIVERSE MOLECULAR ANALYTES
#3009CRISPR-BASED METHODS FOR RECORDING BIOLOGICAL SIGNALS
#3010METHODS AND COMPOSITIONS FOR REPROGRAMMING CELLS
#3011COMPOSITIONS AND METHODS FOR TARGETED DELIVERY OF CRISPR-CAS EFFECTOR POLYPEPTIDES AND TRANSGENES
#3012LIGHT-INDUCIBLE CRISPR/CAS9 SYSTEM FOR GENOME EDITING
#3013Surface-Based Tagmentation
#3014SMALL TYPE II CAS PROTEINS AND METHODS OF USE THEREOF
#30153' UTR CRISPR-DCAS 13 ENGINEERING SYSTEM AND METHODS OF USING SAME
#3016CELL-FREE PRODUCTION OF RIBONUCLEIC ACID
#3017Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
#3018Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
#3019CHLAMYDOMONAS MUTANT AND USE THEREOF
#3020MINIMAL ARRESTIN DOMAIN CONTAINING PROTEIN 1(ARRDC1) CONSTRUCTS
#3021Methods of substituting pathogenic amino acids using programmable base editor systems
#3022LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING OF T CELLS
#3023RNA-guided nucleic acid modifying enzymes and methods of use thereof
#3024GENE EDITING SYSTEMS COMPRISING AN RNA GUIDE TARGETING TRANSTHYRETIN (TTR) AND USES THEREOF
#3025Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
#3026CLOSED PROCESS FOR EXPANSION AND GENE EDITING OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#3027COMPOSITIONS AND METHODS FOR GENE REPLACEMENT
#3028METHODS AND COMPOSITIONS FOR MODULATING PD1
#3029SYSTEM AND METHOD FOR COMBATING INFECTIONS DUE TO PATHOGENS BELONGING TO PHYLUM PROTEOBACTERIA
#3030METHOD FOR IN VITRO TRANSCRIPTION USING AN IMMOBILIZED RESTRICTION ENZYME
#3031TRANSKINGDOM PLATFORM FOR THERAPEUTIC NUCLEIC ACID DELIVERY
#3032CRISPR-RELATED METHODS AND COMPOSITIONS WITH GOVERNING gRNAS
#3033Mbp_Argonaute proteins from prokaryotes and applications thereof
#3034RNA-GUIDED CAS NUCLEASES AND USES THEREOF IN DIAGNOSTICS AND THERAPY
#3035Nucleic acid-guided nucleases
#3036CHIMERIC GENOME ENGINEERING MOLECULES AND METHODS
#3037ENGINEERED CRISPR/CAS13 SYSTEM AND USES THEREOF
#3038DEOXYRIBONUCLEASE VARIANTS AND USES THEREOF
#3039Polypeptide Containing DNA-Binding Domain
#3040Nucleobase editors comprising GeoCas9 and uses thereof
#3041COMPOSITIONS AND METHODS FOR EDITING OF THE CDKL5 GENE
#3042CRISPR CAS SYSTEMS AND LYSOGENY MODULES
#3043COMPOSITIONS AND METHODS COMPRISING VIRAL VECTOR SYSTEMS FOR MULTIPLEXED ACTIVATION OF ENDOGENOUS GENES AS IMMUNOTHERAPY AND VIRAL-BASED IMMUNE-GENE THERAPY
#3044METHODS OF EDITING A SINGLE NUCLEOTIDE POLYMORPHISM USING PROGRAMMABLE BASE EDITOR SYSTEMS
#3045Adeno-Associated Virus-Mediated CRISPR-Cas9 Treatment of Ocular Disease
#3046METHODS AND COMPOSITIONS FOR KILLING A TARGET BACTERIUM
#3047DIFFERENTIAL KNOCKOUT OF AN ALLELE OF A HETEROZYGOUS ELANE GENE USING GUIDES 21-30 NUCLEOTIDES IN LENGTH
#3048Compositions and methods for organ specific delivery of nucleic acids
#3049CRISPR COMPLEX-BASED DETECTION SYSTEM AND METHOD
#3050CRISPR/CAS9 SYSTEM AS AN AGENT FOR INHIBITION OF POLYOMA JC INFECTION
#3051DELIVERY OF INTACT CRISPR/CAS9 PROTEIN USING SUPRAMOLECULAR NANOPARTICLE (SMNP) VECTORS
#3052AAV Expression Cassette and AAV Vectors Comprising the Same
#3053METHOD FOR PRODUCING GENETICALLY EDITED BIRDS HAVING RESISTANCE TO AVIAN INFLUENZA VIRUSES
#3054SYSTEM AND METHOD FOR COMBATING MYCOBACTERIUM TUBERCULOSIS INFECTIONS
#3055UNIVERSAL DNA ASSEMBLY
#3056BASE EDITOR-MEDIATED CD33 REDUCTION TO SELECTIVELY PROTECT THERAPEUTIC CELLS
#3057CRISPR-CAS SYSTEM FOR AN ALGAL HOST CELL
#3058BCL11A GUIDE AND BASE EDITOR DELIVERY
#3059METHODS AND COMPOSITIONS FOR TREATING THALASSEMIA OR SICKLE CELL DISEASE
#3060BASE EDITING SYSTEMS FOR ACHIEVING C TO A AND C TO G BASE MUTATION AND APPLICATION THEREOF
#3061Cleaning compositions comprising enzymes
#3062DNase I variants, compositions, methods, and kits
#3063CONSTRUCTS FOR IMPROVED HDR-DEPENDENT GENOMIC EDITING
#3064METHODS AND COMPOSITIONS FOR KILLING A TARGET BACTERIUM
#3065BROAD SPECTRUM INHIBITORS OF CRISPR-CAS9
#3066A METHOD TO PREPARE PERSONALIZED TARGET-IRRELEVANT GUIDE RNA POOL FOR CRISPR
#3067VITRO ISOLATION AND ENRICHMENT OF NUCLEIC ACIDS USING SITE-SPECIFIC NUCLEASES
#3068METHOD FOR IDENTIFYING 2'O-METHYLATION MODIFICATION IN RNA MOLECULE, AND APPLICATION THEREOF
#3069Crispr enzymes and systems
#3070COMPOSITIONS, SYSTEMS, AND METHODS FOR GENOME EDITING
#3071ORGANELLE GENOME MODIFICATION
#3072COMPOSITIONS AND METHODS FOR HOMOLOGY-DIRECTED RECOMBINATION
#3073Base editing tool and use thereof
#3074Modified Guide RNAs for Gene Editing
#3075IMPROVING CAS NUCLEASE TARGET SPECIFICITY
#3076RNA-guided nucleases and DNA binding proteins
#3077NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS
#3078CRISPR TYPE V-U1 SYSTEM FROM MYCOBACTERIUM MUCOGENICUM AND USES THEREOF
#3079CELL PERMEABLE PROTEINS FOR GENOME ENGINEERING
#3080Compositions and methods for treating hemoglobinopathies
#3081PHAGE COMPOSITIONS COMPRISING CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF
#3082Microbial compositions for improving the efficacy of anticancer treatments based on immune checkpoint inhibitors and/or tyrosine kinase inhibitors and markers of responsiveness to such treatments
#3083COMPOSITIONS FOR DETECTION OF DNA AND METHODS OF USE THEREOF
#3084METHODS FOR IN VITRO JOINING AND COMBINATORIAL ASSEMBLY OF NUCLEIC ACID MOLECULES
#3085WISKOTT-ALDRICH SYNDROME GENE HOMING ENDONUCLEASE VARIANTS, COMPOSITIONS, AND METHODS OF USE
#3086BACTERIAL PLATFORM FOR DELIVERY OF GENE-EDITING SYSTEMS TO EUKARYOTIC CELLS
#3087CRISPR enabled multiplexed genome engineering
#3088HOST SYSTEMS COMPRISING INHIBITORS OF A GENE-EDITING PROTEIN FOR PRODUCTION OF VIRAL VECTORS
#3089METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION
#3090COMPOSITIONS AND METHODS OF REPROGRAMMING T CELLS TO TREAT DISEASE
#3091COMPOSITIONS AND METHODS FOR EDITING THE ANGIOPOIETIN-LIKE 4 (ANGPTL4) GENE
#3092RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE
#3093ENGINEERING IMMUNE ORTHOGANOL AAV AND IMMUNE STEALTH CRISPR-CAS
#3094FUSION PROTEIN THAT IMPROVES GENE EDITING EFFICIENCY AND APPLICATION THEREOF
#3095NOVEL CRISPR ENZYMES AND SYSTEMS
#3096Base editing enzymes
#3097A PROMOTER SPECIFIC FOR NON-PIGMENTED CILIARY EPITHELIAL CELLS
#3098GENERATION OF CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS FROM STEM CELLS AND THERAPEUTIC USES THEREOF
#3099INTRACELLULAR GENOMIC TRANSPLANT AND METHODS OF THERAPY
#3100METHODS AND COMPOSITIONS FOR TREATING CANCER
#3101DNA-BINDING PROTEINS AND USES THEREOF
#3102RAPID CHARACTERIZATION OF CAS ENDONUCLEASE SYSTEMS, PAM SEQUENCES AND GUIDE RNA ELEMENTS
#3103CRISPR-CAS3 FOR MAKING GENOMIC DELETIONS AND INDUCING RECOMBINATION
#3104SGRNA GUIDING PD1 GENE FOR CLEAVAGE TO ACHIEVE EFFICIENT INTEGRATION OF EXOGENOUS SEQUENCES
#3105DEOXYRIBONUCLEASE USES IN DETERGENT COMPOSITION
#3106COMPOSITIONS AND METHODS FOR TRANSGENE EXPRESSION FROM AN ALBUMIN LOCUS
#3107DNMT3A KNOCKOUT CAR T CELLS FOR ADOPTIVE IMMUNOTHERAPY
#3108AUTOMATED INSTRUMENTATION FOR PRODUCTION OF T-CELL RECEPTOR PEPTIDE LIBRARIES
#3109Normalization of Nucleic Acid Samples and Compositions for Use in the Same
#3110RNASE H2 mutants that reduce primer dimers and off-target amplification in RHPCR-based amplicon sequencing with high-fidelity DNA polymerases
#3111METHODS AND COMPOSITIONS FOR GENOME EDITING VIA HAPLOID INDUCTION
#3112COMPOSITIONS AND METHODS FOR THE TARGETING OF SOD1
#3113COMPOSITIONS AND METHODS FOR IMPROVED GENE EDITING
#3114Allosteric conditional guide RNAs for cell-selective regulation of CRISPR/Cas
#3115Compositions and methods for modulating hepatocyte nuclear factor 4-alpha (HNF4α) gene expression
#3116DNA MODIFYING ENZYMES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE
#3117METHODS AND COMPOSITIONS FOR MODULATING FRATAXIN EXPRESSION AND TREATING FRIEDRICH'S ATAXIA
#3118Sequence-specific antimicrobials by blocking DNA repair
#3119SIRPalpha-SILENCED NATURAL KILLER (NK) CELLS
#3120METHOD FOR PRODUCING YEAST EXTRACT
#3121CRISPR-MEDIATED CAPTURE OF NUCLEIC ACIDS
#3122METHODS FOR CHOMOSOME REARRANGEMENT
#3123Cas9 mutant genes and polypeptides encoded by same
#3124MATERIALS AND METHODS FOR TREATMENT OF APOLIPOPROTEIN C3 (APOCIII)-RELATED DISORDERS
#3125RNA-guided nucleases and DNA binding proteins
#3126Genetically engineered cells
#3127VIRAL TARGETING OF HEMATOPOIETIC STEM CELLS
#3128SPLIT INTEIN AND PREPARATION METHOD FOR RECOMBINANT POLYPEPTIDE USING THE SAME
#3129SYSTEMS AND METHODS FOR GENERATING GENETIC INCOMPATIBILITY
#3130Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells
#3131LIVE CELL IMAGING OF NON-REPETITIVE GENOMIC LOCI
#3132METHODS AND PRODUCTS FOR PRODUCING ENGINEERED MAMMALIAN CELL LINES WITH AMPLIFIED TRANSGENES
#3133VECTORIZED EDITING OF NUCLEIC ACIDS TO CORRECT OVERT MUTATIONS
#3134COMPOSITIONS AND METHODS FOR MODIFYING GENOMES
#3135COMPOSITIONS AND METHODS FOR IN VIVO GENE EDITING
#3136COMPOSITIONS, SYSTEMS, AND METHODS FOR GENOME EDITING
#3137Compositions and Methods Relating to Synthetic RNA Polynucleotides Created From Synthetic DNA Oligonucleotides
#3138Polynucleotide encoding modified CAS9 protein
#3139Split CPF1 Protein
#3140ANTIBODY CHEMICALLY INDUCED DIMERIZERS (AbCID) AS MOLECULAR SWITCHES AND USES THEREOF
#3141METHODS OF TREATING LYSOSOMAL STORAGE DISEASES
#3142GENE TRANSFER VECTORS AND METHODS OF ENGINEERING CELLS
#3143PLURIPOTENT STEM CELL, NERVE CELL, AND APPLICATION THEREOF
#3144SYSTEMS AND METHODS FOR PERFORMING AND MEASURING HOMOLOGOUS CHROMOSOME TEMPLATE REPAIR
#3145CRISPR EFFECTOR SYSTEM BASED CORONAVIRUS DIAGNOSTICS
#3146Type III CRISPR/Cas-based Diagnostics
#3147EVALUATION OF CAS9 MOLECULE/GUIDE RNA MOLECULE COMPLEXES
#3148MODIFIED CYANOBACTERIUM, MODIFIED CYANOBACTERIUM PRODUCTION METHOD, AND PROTEIN PRODUCTION METHOD
#3149AUXOTROPHIC SELECTION METHODS
#3150Methods and systems for guide RNA design and use
#3151CRISPR EPIGENETIC THERAPEUTICS FOR PAIN MANAGEMENT
#3152MODIFIED NUCLEIC ACID EDITING SYSTEMS FOR TETHERING DONOR DNA
#3153Compositions, systems, and methods for genome editing
#3154Compositions, systems, and methods for genome editing
#3155ENGINEERED HUMAN IMMUNE CELLS, PREPARATION METHOD AND APPLICATION THEREOF
#3156Epigenomic editing and reactivation of targets for the treatment of Fragile X syndrome
#3157Treatment Of Increased Lipid Levels With Sterol Regulatory Element Binding Protein Cleavage-Activating Protein (SCAP) Inhibitors
#3158METHODS AND COMPOSITIONS FOR TARGETED SINGLE-STRANDED CLEAVAGE AND TARGETED INTEGRATION
#3159METHODS FOR DIAGNOSING THE EFFECTIVENESS OF ANTI-TUMOR TREATMENT
#3160CAS 9 RETROVIRAL INTEGRASE AND CAS 9 RECOMBINASE SYSTEMS FOR TARGETED INCORPORATION OF A DNA SEQUENCE INTO A GENOME OF A CELL OR ORGANISM
#3161GERMACRENE A SYNTHASE MUTANTS
#3162AUGMENTED sgRNAS AND METHODS FOR THEIR USE TO ENHANCE SOMATIC AND GERMLINE PLANT GENOME ENGINEERING
#3163SYSTEMS AND METHODS FOR SINGLE-STRAND BREAK SIGNALING AND REPAIR IN A CELL-FREE SYSTEM AND METHODS OF IDENTIFYING MODULATORS OF SINGLE-STRAND BREAK SIGNALING AND REPAIR
#3164Safe harbor loci
#3165Gene-regulating compositions and methods for improved immunotherapy
#3166Type I CRISPR system as a tool for genome editing
#3167NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS
#3168SPLIT CRISPR NUCLEASE TETHERING SYSTEM
#3169BASE EDITORS WITH DIVERSIFIED TARGETING SCOPE
#3170COMPOSITIONS AND METHODS FOR EDITING A MUTATION TO PERMIT TRANSCRIPTION OR EXPRESSION
#3171SEQUENCE-SPECIFIC IN VIVO CELL TARGETING
#3172METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#3173CD52-DEFICIENT CELLS FOR ADOPTIVE CELL THERAPY
#3174METHOD AND SYSTEM FOR IDENTIFICATION OF CANDIDATE TARGET SITES FOR COMBATING PATHOGENS
#3175Method for Removing and/or Detecting Nucleic Acids Having Mismatched Nucleotides
#3176CRISPR COMPOSITIONS AND METHODS FOR PROMOTING GENE EDITING OF GATA2
#3177ENGINEERED GUIDE RNA FOR THE OPTIMIZED CRISPR/Cas12f1 SYSTEM AND USE THEREOF
#3178COMPOSITIONS AND METHODS FOR IDENTIFYING REGULATORS OF CELL TYPE FATE SPECIFICATION
#3179Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells via viral delivery
#3180MODIFIED BACTERIAL RETROELEMENT WITH ENHANCED DNA PRODUCTION
#3181ADENINE BASE EDITORS WITH REDUCED OFF-TARGET EFFECTS
#3182EVOLVED CAS9 VARIANTS AND USES THEREOF
#3183Nucleic acid binding domains and methods of use thereof
#3184SKELETAL MYOBLAST PROGENITOR CELL LINEAGE SPECIFICATION BY CRISPR/CAS9-BASED TRANSCRIPTIONAL ACTIVATORS
#3185COMPOSITIONS AND METHODS FOR MULTIPLEXED QUANTITATIVE ANALYSIS OF CELL LINEAGES
#3186NDUFS2 SUBUNIT KNOCKOUT HUMAN CELL LINE
#3187Method for analyzing target particle, analytical reagent, and analyzer
#3188GENETICALLY MODIFIED PLANTS AND METHODS OF MAKING THE SAME
#3189COMPOSITIONS AND METHODS FOR IMPROVING POD SHATTER TOLERANCE IN CANOLA
#3190POD SHATTER TOLERANCE IN BRASSICA PLANTS
#3191COUNTER-SELECTION BY INHIBITION OF CONDITIONALLY ESSENTIAL GENES
#3192NUCLEASE AND NICKASE FUSION PROTEINS FOR INCREASED HOMOLOGOUS RECOMBINATION IN MAMMALIAN CELLS
#3193CRISPR-ASSOCIATED MU TRANSPOSASE SYSTEMS
#3194COMPOSITIONS FOR REGULATING AND SELF-INACTIVATING ENZYME EXPRESSION AND METHODS FOR MODULATING OFF-TARGET ACTIVITY OF ENZYMES
#3195NOVEL GENOME EDITING TOOL
#3196ENZYMES WITH RUVC DOMAINS
#3197Compositions and Methods for Modulation of Gene Expression
#3198Class II, type V CRISPR systems
#3199GENE EDITING USING A MODIFIED CLOSED-ENDED DNA (CEDNA)
#3200COMPOSITIONS AND METHODS FOR EXCISION WITH SINGLE GRNA
#3201RECOMBINANT RABIES VIRUSES FOR GENE THERAPY
#3202ACOUSTIC REMOTE CONTROL OF MICROBIAL IMMUNOTHERAPY
#3203METHODS AND COMPOSITIONS FOR GENE SPECIFIC DEMETHYLATION AND ACTIVATION
#3204Highly Efficient DNA Base Editors Mediated By RNA-Aptamer Recruitment For Targeted Genome Modification And Uses Thereof
#3205Engineered CRISPR/Cas9 Systems for Simultaneous Long-term Regulation of Multiple Targets
#3206COMPOSITIONS, KITS, AND METHODS FOR ANALYSIS OF DNA SEQUENCE-SPECIFICITY IN V(D)J RECOMBINATION
#3207RNA AFFINITY PURIFICATION
#3208Combinatorial Adenine and Cytosine DNA Base Editors
#3209High efficiency base editors comprising Gam
#3210PROGRAMMABLE DNA BASE EDITING BY NME2CAS9-DEAMINASE FUSION PROTEINS
#3211METHODS AND COMPOSITIONS USING AUXOTROPHIC REGULATABLE CELLS
#3212GENETICALLY ENGINEERED T CELLS WITH PTPN2 KNOCKOUT HAVE IMPROVED FUNCTIONALITY AND ANTI-TUMOR ACTIVITY
#3213METHOD FOR PRODUCING NK CELLS WITH PD-1 KNOCKOUT GENE AND TRAIL OR FAS-LIGAND OVEREXPRESSION
#3214COMPOSITIONS AND METHODS IDENTIFYING AND USING STEM CELL DIFFERENTIATION MARKERS
#3215NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS
#3216GENETICALLY-EDITED IMMUNE CELLS AND METHODS OF THERAPY
#3217CRISPR GENOME EDITING WITH CELL SURFACE DISPLAY TO PRODUCE HOMOZYGOUSLY EDITED EUKARYOTIC CELLS
#3218NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS
#3219RNA GUIDE GENOME EDITING IN CITRUS USING CRISPR-RIBONUCLEOPROTEIN COMPLEXES
#3220COMPOSITIONS AND METHODS OF NUCLEIC ACID-TARGETING NUCLEIC ACIDS
#3221COMPOSITIONS AND METHODS FOR INCREASED PROTEIN PRODUCTION IN BACILLUS LICHENFORMIS
#3222Cleavage of Single Stranded DNA Having a Modified Nucleotide
#3223POLYPEPTIDE VARIANTS
#3224FASL EXPRESSION AND FASR GENE KNOCKOUT TO PROTECT THERAPEUTIC CELLS FROM ALLOGENEIC REJECTION AND ACTIVATION-INDUCED CELL DEATH
#3225Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
#3226GENETIC MUTATIONAL ANALYSIS
#3227COMPOSITIONS AND METHODS FOR IN UTERO GENE EDITING FOR MONOGENIC LUNG DISEASE
#3228METHOD FOR ENCODING DNA/RNA SEQUENCES BASED ON BIDIRECTIONAL TRINUCLEOTIDE POSITION-SPECIFIC PROPENSITIES AND POINTWISE JOINT MUTUAL INFORMATION
#3229METHODS FOR SCALABLE GENE INSERTIONS
#3230Application of a fragment of an isolated nucleotide sequence in construction of non-mineralized intermuscular bone of
#3231ABIOTIC STRESS TOLERANT PLANTS AND METHODS
#3232Dual strand nucleic acid-guided nickase editing
#3233VIVO GUIDE RNA LIBRARIES AND METHODS OF MAKING THE SAME
#3234METHODS FOR IDENTIFYING GENOMIC SAFE HARBORS
#3235BASE EDITORS WITH IMPROVED PRECISION AND SPECIFICITY
#3236TEMPERATURE-SENSITIVE RNA- Guided Endonuclease
#3237COMPOSITIONS AND METHODS FOR SEQUENTIAL STACKING OF NUCLEIC ACID SEQUENCES INTO A GENOMIC LOCUS
#3238Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3239CRISPR MULTI-TARGET DETECTION METHOD AND TEST KIT THEREFOR
#3240ANTI-POLLUTION CONSUMABLE AND METHOD FOR CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR) MOLECULAR DIAGNOSIS USING SAME
#3241MULTIPLEXED ENGINEERED CELLS AND SYSTEMS FOR BIOFUEL PRODUCTION
#3242Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3243Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3244Nuclease-independent targeted gene editing platform and uses thereof
#3245Creation of herbicide resistant gene and use thereof
#3246Targeted RNA cleavage with CRISPR-Cas
#3247COMPOSITIONS AND METHODS FOR MODULATING GENOMIC COMPLEX INTEGRITY INDEX
#3248Cascade/dCas3 Complementation Assays for In Vivo Detection of Nucleic Acid-Guided Nuclease Edited Cells
#3249HSD17B13 variants and uses thereof
#3250DUX4 EXPRESSING CELLS AND USES THEREOF
#3251Gene-regulating compositions and methods for improved immunotherapy
#3252Gene Editing to Improve Joint Function
#3253IMMUNE CELLS EXPRESSING ENGINEERED ANTIGEN RECEPTORS
#3254Methods and systems for identifying target genes
#3255Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3256METHODS AND COMPOSITIONS FOR MODIFYING CYTOKININ OXIDASE LEVELS IN PLANTS
#3257MODIFIED CELL
#3258CONTROL OF MAMMALIAN GENE DOSAGE USING CRISPR
#3259ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES
#3260MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES
#3261RECOMBINANT AD35 VECTORS AND RELATED GENE THERAPY IMPROVEMENTS
#3262CIRCULAR RNAS FOR CELLULAR THERAPY
#3263ENGINEERED OFF-THE-SHELF IMMUNE CELLS AND METHODS OF USE THEREOF
#3264GENETIC MODIFICATION NON-HUMAN ORGANISM, EGG CELLS, FERTILIZED EGGS, AND METHOD FOR MODIFYING TARGET GENES
#3265METHODS AND SYSTEMS FOR IDENTIFYING TARGET GENES
#3266PORTABLE DEVICES AND METHODS FOR DETECTING AND IDENTIFYING COMPOUNDS IN A FLUID SAMPLE
#3267SYSTEMS AND METHODS FOR DETECTING THE PRESENCE OF AN ANALYTE, SUCH AS SARS-COV-2, IN A SAMPLE
#3268mRNA NANOCAPSULE AND USE IN PREPARATION OF ANTIVIRAL DRUGS
#3269Methods and compositions for generating complex trait loci
#3270INIR6 transgenic maize
#3271Modulation of Engineered Immune Cell Receptor Translation Using Noncoding Sequence Elements
#3272CELLS ENGINEERED FOR OLIGONUCLEOTIDE DELIVERY, AND METHODS FOR MAKING AND USING THEREOF
#3273Compositions and methods for disrupting the molecular mechanisms associated with mitochondrial dysfunction and neurodegenerative disease
#3274METHODS FOR EXTENDING THE REPLICATIVE CAPACITY OF SOMATIC CELLS DURING AN EX VIVO CULTIVATION PROCESS
#3275Methods and kits for identifying cancer treatment targets
#3276Inhibition of nucleic acid polymerases by endonuclease V-cleavable circular oligonucleotide ligands
#3277ARTIFICIAL EXPRESSION CONSTRUCTS FOR SELECTIVELY MODULATING GENE EXPRESSION IN SELECTED NEURONAL CELL POPULATIONS
#3278COMPOSITIONS AND METHODS FOR TARGETING MULTINUCLEATED CELLS
#3279AAV DELIVERY OF NUCLEOBASE EDITORS
#3280Phosphonate-Drug Conjugates
#3281Methods of and compositions for reducing gene expression and/or activity
#3282COMPOSITIONS COMPRISING AN ENDONUCLEASE AND METHODS FOR PURIFYING AN ENDONUCLEASE
#3283ALLOGENEIC CELL THERAPY OF B CELL MALIGNANCIES USING GENETICALLY ENGINEERED T CELLS TARGETING CD19
#3284A GENETIC PHARMACOPEIA FOR COMPREHENSIVE FUNCTIONAL PROFILING OF HUMAN CANCERS
#3285Automated instrumentation for production of T-cell receptor peptide libraries
#3286METHODS AND PRODUCTS FOR EXPRESSING PROTEINS IN CELLS
#3287Transposition-based therapies
#3288Engineered muscle targeting compositions
#3289METHODS OF PRODUCING PLANTS WITH ALTERED FRUIT DEVELOPMENT AND PLANTS DERIVED THEREFROM
#3290ANTI-CRISPR INHIBITORS
#3291ENGINEERED MEGANUCLEASES SPECIFIC FOR RECOGNITION SEQUENCES IN THE HEPATITIS B VIRUS GENOME
#3292FUSION PROTEIN FOR NATURAL KILLER CELL SPECIFIC CRISPR/CAS SYSTEM AND USE THEREOF
#3293ENGINEERED Cas-Transposon SYSTEM FOR PROGRAMMABLE AND SITE-DIRECTED DNA TRANSPOSITIONS
#3294METHODS FOR TREATING METABOLIC DISORDERS BY TARGETING ADCY5
#3295Method for isolating and culturing neural stem cells with high efficiency
#3296OPTIMIZED GENETIC TOOL FOR MODIFYING BACTERIA
#3297TREATMENT OF DISEASES ASSOCIATED WITH PROTEIN MISFOLDING BY NERVOUS SYSTEM EXPRESSION OF AN ENZYME WHICH HAS A DEOXYRIBONUCLEASE (DNase) ACTIVITY
#3298Targeted replacement of endogenous T cell receptors
#3299RNA targeting methods and compositions
#3300SYSTEMS AND METHODS FOR PREDICTING REPAIR OUTCOMES IN GENETIC ENGINEERING